Jason Gerberry Analyst PerformanceEquity Research at Bank of AmericaJason Gerberry is a stock analyst at Bank of America focused in the medical sector, covering 44 publicly traded companies. Over the past year, Jason Gerberry has issued 14 stock ratings, including buy, hold, and sell recommendations. While full access to Jason Gerberry's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Jason Gerberry's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings201 Last 11 YearsBuy Recommendations74.87% 149 Buy RatingsCompanies Covered44 Unique Companies Ratings Distribution199RatingsDistribution of strong buy, buy, hold, and sell ratings by Jason Gerberry.RatingPercentageCount Strong Buy0.0%0 ratings Buy74.9%149 ratings Hold22.1%44 ratings Sell3.0%6 ratingsOut of 199 total stock ratings issued by Jason Gerberry at Bank of America, the majority (74.9%) have been Buy recommendations, followed by 22.1% Hold and 3.0% Sell.Best & Worst CallsBest Call0000.0%CORIJan 2017Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%DEPOOct 2016Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ77.3% of companies on NASDAQ34 companiesNYSE22.7% of companies on NYSE10 companiesJason Gerberry, an analyst at Bank of America, currently covers 44 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical42 companies95.5%Miscellaneous2 companies4.5%Jason Gerberry of Bank of America specializes in stock coverage within the Medical sector, with additional focus on companies.Coverage IndustriesIndustryPercentagePHARMACEUTICAL PREPARATIONS13 companies29.5%MED - BIOMED/GENE12 companies27.3%MED - DRUGS6 companies13.6%LARGE CAP PHARMA4 companies9.1%BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC3 companies6.8%MED - GENERIC DRG2 companies4.5%Miscellaneous2 companies4.5%MEDICAL SERVICES1 company2.3%MED PRODUCTS1 company2.3% Jason Gerberry's Ratings History at Bank of America Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export to Excel CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsAMPHAmphastar Pharmaceuticals8/26/2025Boost Price Target$30.54$32.00Neutral$0.0000.00% ROIIMVTImmunovant8/12/2025Lower Price Target$14.76$30.00Buy$0.0000.00% ROIBHVNBiohaven8/12/2025Lower Price Target$13.42$49.00Buy$0.0000.00% ROIAXSMAxsome Therapeutics8/5/2025Boost Price Target$102.86$176.00Buy$0.0000.00% ROIPROKProKidney6/30/2025Downgrade$0.67$1.00Underperform$0.0000.00% ROILQDALiquidia Technologies6/11/2025Lower Price Target$14.34$23.00Buy$0.0000.00% ROIEXELExelixis6/5/2025Boost Price Target$42.55$46.00Neutral$0.0000.00% ROITEVATeva Pharmaceutical Industries5/8/2025Boost Price Target$18.08$22.00Buy$0.0000.00% ROIPCVXVaxcyte4/1/2025Lower Price Target$36.81$137.00Buy$0.0000.00% ROIIMVTImmunovant3/20/2025Lower Price Target$18.88$33.00Buy$0.0000.00% ROITEVATeva Pharmaceutical Industries3/6/2025Lower Price Target$15.59$20.00Buy$0.0000.00% ROIVTRSViatris2/28/2025Lower Price Target$9.53$10.00Underperform$0.0000.00% ROIAXSMAxsome Therapeutics2/11/2025Boost Price Target$133.41$167.00Buy$0.0000.00% ROIIMVTImmunovant1/15/2025Lower Price Target$22.88$45.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
